Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.50
Bid: 4.00
Ask: 5.00
Change: 0.50 (12.50%)
Spread: 1.00 (25.00%)
Open: 4.00
High: 4.50
Low: 4.00
Prev. Close: 4.00

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

24 Jul 2023 07:00

RNS Number : 8515G
Norman Broadbent PLC
24 July 2023
 

 24 July 2023

 

 

Norman Broadbent plc

("Norman Broadbent" or the "Company" or the "Group")

 

Interim results for the six months ended 30 June 2023

 

Norman Broadbent plc (AIM: NBB), a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, is pleased to announce its unaudited interim results for the six months ended 30 June 2023 ("H1 2023").

Financial Highlights

· Revenue growth of 54% to £6.1m (H1 2022: £3.9m). 

· Underlying1 EBITDA of £0.27m up almost 400% (H1 2022: £0.06m).

- Reflects the improvements made in the culture, brand, headcount growth and quality and seniority of mandates secured.

· Profit after tax of £8,000 (H1 2022: loss after tax £72,000). First profitable H1 since 2019.

· Net cash generated by operating activities of £0.05m (H1 2022: net cash used (£0.50m)).

· Repaid £0.2m of Convertible Loan Notes ("CLNs") in May 2023.

- The balance of £0.2m is expected to be repaid before the second anniversary of issue.

Operational Highlights

· Net fee income ("NFI") up 58% to £5.2m (H1 2022: £3.3m).

- Q2 2023 NFI increased by 50% to £2.7m (Q2 2022: £1.8m).

- Executive Search NFI grew by 58% to £4.1m (H1 2022: £2.6m). 

- Interim Management NFI was up 43% to £1.0m (H1 2022: £0.7m).

- £1.0m of NFI generated in June 2023 alone the highest achieved under the new management team to date in a single month

· Average new search fee value increased by 43% and average NFI per fee earner up 13% compared to H1 2022. 

· 35% growth in fee earner headcount since 30 June 2022 with additional high-quality hires in train for H2 2023.

· Implementation of improved technology platforms in 2023 with new finance system, HR platform and expense management tool, all of which will provide improved management information and support accelerated growth.

 

[1] Underlying EBITDA excludes share based payment charges

 

Kevin Davidson, CEO of Norman Broadbent, said: "I am delighted to be announcing such strong results which demonstrate the quality and dedication of the team and the culture of excellence which we have established together over the past couple of years. This platform has enabled us to retain and hire exceptional talent in a market which continues to be extremely competitive.

 

We have strengthened the business in all areas with economies of scale and efficiency improvements beginning to benefit the bottom line. Having delivered a profit after tax for the first time since H1 2019, the substantial carried forward tax losses of over £14m begin to be of significant value as we expect to deliver sustainable and accelerated growth in the years ahead.

 

Despite a challenging market, we look forward with confidence and excitement about what can be achieved again at Norman Broadbent. Looking ahead, we remain conscious of the macro-economic environment, but continue to see a strong pipeline of opportunities giving us confidence as we head into H2. I thank everyone in the team for their continued dedication, our clients for choosing to work with us and our investors for their continued support."

 

For further Information, please contact:

Norman Broadbent plc   020 7484 0000

Kevin Davidson, CEO

Mehr Malik, CFO

 

Shore Capital (Nominated Adviser and Broker) 020 7408 4090

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

Copies of this announcement are available on the Company's website at www.normanbroadbent.com.

CEO's Statement

 

Norman Broadbent has delivered considerable growth in headcount, capability and capacity in H1 2023 whilst also generating positive EBITDA. With NFI up 58% and underlying EBITDA up almost 400%, we are delighted to have delivered the Company's best results for some time.

 

New hires continue to establish themselves rapidly and H1 2023 has seen us deepen our capabilities and reach across our key sectors and corporate functions, including Industrial, Investor, Digital & Technology, Life-Sciences, Finance and Change & Transformation. As we enter H2 2023, the Company has already secured an additional fee earner to accelerate the development of our Board Practice. There are other fee generating hires in process and we remain disciplined in terms of quality and cultural alignment on all prospective recruits.

 

In H1 2023, the Company placed leaders across the UK and Europe, the US, South America, the Middle East and Asia. It has purposefully developed its international client base and brand over the past two years and it is very pleasing to see that 29% of H1 2023's NFI was generated from international assignments (H1 2022: 24%). This international spread of business enables the Company to capitalise fully on global key accounts, secure the most senior mandates, mitigate risk and open multiple fronts for continued growth. The Board does not declare the payment of an interim dividend (2022: nil pence).

 

As it has scaled, the Company has also focused heavily on processes, systems and team development to ensure efficiency and consistency. This, coupled with the rapidly rising quality and seniority of mandates, has enabled the Company to grow NFI in an increasingly accretive way as efficiencies are realised within the research and support teams.

 

Summarised Financial Results:

 

The table below summarises the financial results for the Group:

 

 

Six months to 30 Jun

2023

Six months to 30 Jun

2022

Year ended

31 Dec

2022

£000's

(unaudited)

£000's

(unaudited)

£000's

(audited)

 

 

 

 

Revenue

6,057

3,936

8,697

Cost of sales

(879)

(640)

 (1,350)

 

 

Gross profit (Net Fee Income)

5,178

3,296

7,347

Operating expenses

(4,907)

(3,241)

(7,254)

 

 

 

 

Underlying EBITDA[1]

271

55

93

Share based payment charge

(82)

-

(131)

EBITDA

189

55

(38)

 

Depreciation and amortisation

(111)

(104)

(223)

 

 

Group operating profit/(loss) before tax

78

(49)

(261)

Net finance cost

 (70)

(23)

(77)

Profit/(loss) before tax

8

(72)

(338)

Income tax expense

-

-

-

Profit/(loss) after tax

8

(72)

(338)

 

 

Financial Position

 

As at 30 June 2023, equity shareholders' funds were £0.76m (30 June 2022: £0.764m), with net current liabilities of £0.762m (30 June 2022: £0.646m). Cash and cash equivalents at 30 June 2023 amounted to £81,000 (30 June 2022: £64,000). Net debt (excluding lease liabilities had improved to £1.2m (30 June 2022: £1.4m) reflecting partial repayment of the CLNs. Net debt post-lease liabilities at 30 June 2023 had reduced to £1.4m (30 June 2022: £1.8m).

 

Net cash inflow from operations was £52,000 (H1 2022: outflow of £495,000) and net cash inflow from financing activities amounted to £8,000 (H1 2022: inflow of £173,000).

 

Outlook

 

Despite the extremely challenging economic backdrop, Norman Broadbent has continued to deliver against its successful revitalisation and growth agenda, delivering rapid and sustainable profit growth.

 

As the Company continues to re-establish itself as a pre-eminent force in executive search and senior interim management across the UK and internationally, the Board is monitoring carefully the evolving macro-economic climate. The Board continues to believe that the Company is very well positioned in more stable and growing markets, notably across Industrials and, in particular, Energy, Power, Chemicals, Transport & Infrastructure, including Civil Aviation. All of these sectors continue to attract significant capital investment whilst also experiencing extreme imbalances in the supply of, and demand for, senior leadership talent. The Company is also effectively leveraging its functional expertise across these markets, particularly in Digital & Tech, Finance, HR and Change & Transformation.

 

With considerable forward momentum, the Board is confident of delivering strong results in H2 2023 and is increasingly confident about achieving its medium-term target of £1.25 million of EBITDA by 2025.

 

Kevin Davidson

Chief Executive

24 July 2023

 

 

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 30 June 2023

 

 

 

Note

Six months ended

Six months ended

Year ended

 

 

30 June

30 June

31 December

 

 

2023

2022

2022

 

 

(unaudited)

(unaudited)

(unaudited)

 

 

£000

£000

£000

 

 

 

Revenue

2

6,057

3,936

8,697

 

 

 

Cost of Sales

 

(879)

(640)

(1,350)

 

 

 

Gross profit (Net Fee Income)

 

 

5,178

3,296

7,347

Operating expenses

 

(5,100)

(3,345)

(7,608)

 

 

Operating profit / (loss) from continued operations

 

78

(49)

(261)

Net finance cost

 

(70)

(23)

(77)

Profit /(loss) on ordinary activities before income tax

 

8

(72)

(338)

 

 

 

Income tax expense

 

 

-

-

 

Total comprehensive profit / (loss) for the period

 

8

(72)

(338)

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit/(loss) per share

3

 

 - Basic

 

0.01p

(0.12p)

(0.56p)

 - Diluted

 

0.01p

(0.12p)

(0.56p)

 

 

Adjusted profit/(loss) per share

 

 

 - Basic

 

0.14p

(0.12p)

(0.34p)

 - Diluted

 

0.14p

(0.12p)

(0.34p)

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 June 2023

 

Note

As at

As at

As at

 

30 June

30 June

31 December

 

2023

2022

2022

 

(unaudited)

(unaudited)

(unaudited)

 

£000

£000

£000

Non-current assets

 

 

Intangible assets

1,363

1,363

1,363

Property, plant and equipment

301

472

402

Total non-current assets

 

1,664

1,835

1,765

 

Current assets

 

Trade and other receivables

3,143

1,998

2,320

Cash and cash equivalents

81

64

50

Total current assets

 

3,224

2,062

2,370

 

Total assets

 

4,888

3,897

4,135

 

Current Liabilities

 

Trade and other payables

2,609

1,260

2,006

Bank Loans and Loan Note

4

1,140

1,256

483

Lease liabilities

237

192

203

Total current liabilities

 

3,986

2,708

2,692

 

 

 

Net current liabilities

(762)

(646)

(322)

 

 

 

Non Current Liabilities

 

Lease liabilities

9

242

155

Bank Loan and Loan Note

4

133

183

618

142

425

773

 

Total liabilities

 

4,128

3,133

3,465

 

Total assets less total liabilities

 

760

764

670

 

Equity

 

Issued share capital

6,345

6,334

6,345

Share premium account

14,110

14,080

14,110

Retained earnings

(19,695)

(19,650)

(19,785)

 

Total equity

 

760

764

670

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the six months ended 30 June 2023

 

 

Share Capital

Share Premium

Retained Earnings

Total Equity

 

£000

£000

£000

£000

Balance at 1 January 2022

6,334

14,080

(19,578)

836

Loss for the period

-

-

(72)

(72)

Total comprehensive loss for the period

-

-

(72)

(72)

Balance at 30 June 2022 (unaudited)

6,334

14,080

(19,650)

764

Balance at 1 July 2022

6,334

14,080

(19,650)

764

Loss for the period

-

-

(266)

(266)

Total other comprehensive income

-

-

-

-

Total comprehensive loss for the period

-

-

(266)

(266)

Transactions with owners of the Company, recognised directly in equity

 

 

 

 

Issue of ordinary shares

11

30

-

41

Credit to equity for share based payments

-

-

131

131

 

 

 

 

 

Total transactions with owners of the Company

11

30

131

172

Balance at 31 December 2022 (audited)

6,345

14,110

(19,785)

670

Balance at 1 January 2023

6,345

14,110

(19,785)

670

Profit for the period

-

-

8

8

Total comprehensive profit for the period

-

-

8

8

Transactions with owners of the Company, recognised directly in equity:

 

 

 

 

 

Credit to equity for share based payments

-

-

82

82

Balance at 30 June 2023 (unaudited)

6,345

14,110

(19,695)

760

 

 

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOW

 For the six months ended 30 June 2023

 

 

 

Note

Six months ended 30 June 2023 (unaudited)

Six months ended 30 June 2022 (unaudited)

 Year ended

31 December 2022

(audited)

 

£000

£000

£000

 

 

Net cash generated by / (used in) operating activities

(i)

52

(495)

(33)

 

Cash flows from investing activities and servicing of finance

 

 

Net finance cost

(18)

(23)

(51)

Payments to acquire tangible fixed assets

 

(11)

(50)

(65)

 

Net cash generated by / (used in) investing activities

 

(29)

 

(73)

(116)

 

Cash flows from financing activities

 

Repayment of borrowings

(257)

(22)

(32)

Proceeds from issue of capital

-

-

41

Increase / (decrease) in invoice discounting

386

(141)

(469)

New Loans received

-

400

400

Payment of finance lease liabilities

(121)

(64)

(200)

 

 

Net cash from financing activities

 

8

 

173

 

(260)

 

Net (decrease)/ increase in cash and cash equivalents

31

 (395)

(409)

Net cash and cash equivalents at beginning of period

50

459

459

Effects of exchange rate changes on cash balances held in foreign currencies

-

-

 

-

 

 

Net cash and cash equivalents at end of period

 

81

 

64

 

50

 

 

Analysis of net funds (pre lease liabilities)

 

Cash and cash equivalents

81

64

50

Borrowings due within one year

Borrowings due within more than one year

(1,140)

(133)

(1,256)

(183)

(483)

(618)

 

 

Net debt

 

(1,192)

 

(1,375)

 

(1,051)

 

 

Note (i)

 

Reconciliation of operating profit to net cash from operating activities

Six months ended 30 June 2023 (unaudited)

Six months ended 30 June 2022 (unaudited)

Year ended 31 December 2022

(audited)

 

Operating profit / (loss) from continued operations

 

78

 

(49)

(261)

Depreciation/amortisation of property, plant and equipment

111

104

223

 

Share based payment charge

82

-

131

(Increase)/decrease in trade and other receivables

(823)

(83)

(405)

Increase/(decrease) in trade and other payables

604

(467)

279

 

Net cash generated by / (used in) operating activities

 

 

 

52

 

(495)

 

(33)

 

 

NOTES TO THE FINANCIAL STATEMENTS

 

1. ACCOUNTING POLICIES

1.1 Basis of preparation

The financial information set out in these interim financial statements does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the year ended 31 December 2022, prepared under International Financial Reporting Standards (IFRS), have been filed with the Registrar of Companies. The auditor's report on those statements was unqualified.

 

The interim financial information for the six months ended 30 June 2023, has been prepared in accordance with the AIM Rules for Companies. The Group has not elected to apply IAS 34 'Interim Financial Reporting'. The principal accounting policies used in preparing the interim results are those the Group expects to apply in its financial statements for the year ending 31 December 2023 and are unchanged from those disclosed in the Group's Annual Report for the year ended 31 December 2022. The interim financial statements have not been audited.

 

1.2 Basis of consolidation and business combinations

Group financial statements consolidate those of the Company and of the following subsidiary undertakings:

Principal Group investments:

 

Country of incorporation or registration and operation

Principal activities

Description and proportion of shares held by the Company

Norman Broadbent Executive Search Ltd

England and Wales

Executive Search

100 per cent ordinary shares

Norman Broadbent (Ireland) Ltd

Republic of Ireland

Dormant

100 per cent ordinary shares

 

 

 

2. SEGMENTAL ANALYSIS

Group revenues are primarily driven from UK operations. However, when revenue is derived from overseas business, the results are presented to the Board by geographic region to identify potential areas for growth or those posing potential risks to the Group.

 

i) Revenue by class of business:

Revenue £'000

Six Months Ended

Six Months Ended

Year Ended

30 June

30 June

31 December

2023

2022

2022

(unaudited)

(unaudited)

(audited)

Search

4,062

2,555

5,666

Interim Management

1,776

1,378

2,920

Leadership consulting

219

3

111

Total

6,057

3,936

8,697

 

ii) Revenue and gross profit by geography:

Revenue £'000

Gross Profit £'000

Six Months Ended

Year Ended

Six Months Ended

Year Ended

30 June

30 June

31 December

30 June

30 June

31 December

2023

2022

2022

2023

2022

2022

(unaudited)

(unaudited)

(audited)

(unaudited)

(unaudited)

(audited)

United Kingdom

4,513

3,159

6,660

3,652

2,519

5,627

Rest of World

1,544

777

2,037

1,526

777

1,720

Total

6,057

3,936

8,697

5,178

3,296

7,347

 

 

3. Profit/(LOSs) PER ORDINARY SHARE

 

i) Basic profit/(loss) per share:

 

This is calculated by dividing the profit/(loss) attributable to equity holders of the Company by the weighted average number of ordinary shares in issue during the period:

 

 

Six Months Ended

Year Ended

 

30 June

30 June

31 December

 

2023

2022

2022

(unaudited)

(unaudited)

(audited)

Profit/(loss) attributable to shareholders (£)

8,000

(72,000)

(338,000)

Weighted average number of ordinary shares

61,817,510

60,740,575

60,879,205

 

 

 

ii) Diluted profit/(loss) per share:

 

This is calculated by adjusting the weighted average number of ordinary shares outstanding to assume conversion of all potentially dilutive issues of ordinary shares. The Company has issued share options which are potentially dilutive. A calculation is done to determine the number of shares that could have been acquired at fair value (determined as the average annual price of the Company's shares) based on the monetary value of the subscription rights attached to the outstanding options. The number of shares calculated as above is compared with the number of shares that would have been issued assuming the exercise of the share options.

 

 

 

Six months ended 30 June 2023

Six months ended 30 June 2022

Year ended 31 December 2022

(unaudited)

(unaudited)

(audited)

Profit/(loss) attributable to shareholders (£)

8,000

(72,000)

(338,000)

 

Weighted average no. of ordinary shares

61,817,510

60,740,757

60,879,205

 

 

Weighted average number of ordinary shares for diluted earnings per share

61,817,510

60,740,757

60,879,205

 

 

iii) Adjusted profit/(loss) per share

 

Adjusted profit/(loss) per share has also been calculated in addition to the basic and diluted loss per share and is based on losses adjusted to eliminate charges for share based payments. It has been calculated to allow shareholders to gain a clearer understanding of the trading performance of the Group.

 

Six months ended 30 June 2023

Six months ended 30 June 2022

Year ended 31 December 2022

(unaudited)

(unaudited)

(audited)

 

Basic

Diluted

Basic

Diluted

Basic

Diluted

 

pence per

pence per

pence per

pence per

pence per

pence per

 

share

share

share

share

share

share

£000

 

£000

£000

Basic earnings

Profit/(loss) after tax

8

0.01

0.01

(72)

(0.12)

(0.12)

(338)

(0.56)

(0.56)

Adjustment

 

 

 

Share based payment charge

82

0.13

0.13

-

-

-

131

0.22

0.22

 

 

 

Adjusted earnings

90

0.14

0.14

(72)

(0.12)

(0.12)

(207)

(0.34)

(0.34)

 

 

 

 

 

4. BORROWINGS

 

Six months ended

Six months ended

Year ended

30 June

30 June

31 December

2023

2022

2022

(unaudited)

(unaudited)

(audited)

£000

£000

£000

Invoice discounting facility (see note (a) below)

869

811

483

Loans (see note (b) below)

404

628

618

 

 

Total

1,273

1,439

1,101

 

 

(a) Invoice discounting facility

 

The Group operates an invoice discounting facility with Metro Bank. All Group invoices are raised through Norman Broadbent Executive Search Limited and as such Metrobank (SME Invoice Finance Limited) holds an all asset debenture for Norman Broadbent plc and Norman Broadbent Executive Search Limited. At as 30 June 2023, the outstanding balance on the facility of £0.9m was secured by trade receivables of £2.7m. Interest is charged on the drawn down funds at a rate of 2.4% above the bank base rate.

 

(b) Loans

 

In November 2020, the Group received a CBILS loan of £250,000 for a term of 6 years. Repayment of capital and interest began in January 2022, and the loan incurs interest at 4.75% above the Metro Bank UK base rate. Metro Bank holds an all asset fixed and floating charge over Norman Broadbent Executive Search Limited linked to this facility.

On 20 May 2022, a total of £400,000 nominal value of CLNs were issued to Downing Strategic Micro-Cap Investment Trust Plc and Moulton Goodies Limited, each of whom subscribed £200,000. On 19 May 2023, £200,000 nominal value of CLNs was repaid. Each of Downing Strategic Micro-Cap Investment Trust Plc and Moulton Goodies Limited holds £100,000 of CLNs of which up to 50% of the outstanding amount is convertible plus any compounded interest in accordance with the terms of the secured loan instrument and security provided by Norman Broadbent Executive Search Limited.

 


[1] Underlying EBITDA excludes share based payment charges

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR ZFLFLXDLEBBZ
Date   Source Headline
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Free Investment Tools

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.